Kenox Pharma partners with Lactiga for development of novel mucosal-targeted Secretory IgA therapies for immunodeficient patients: Princeton, New Jersey Wednesday, March 12, 2025, ...

The simulator also controls the strength of exhalations, meaning that the team could investigate how this and the size of nasal airways affects aerosol cloud dispersion. During their experiments, ...

Kenox specializes in pharmaceutical aerosol product development, including soft mist inhalers (SMIs), pressurized metered-dose inhalers (pMDIs), dry powder inhalers (DPIs), nebulizers, nasal ...

Maintaining a good nasal hygiene with saline-based nasal sprays ... Maintaining physical separation of >,6 feet interrupts aerosol transmission Managing the symptomsIn case the symptoms are ...